The Competition and Markets Authority just secured a court ruling upholding unfair drug pricing findings. Here's what it means for pharmaceutical pricing strategy and competition law enforcement across the healthcare sector.

1️⃣ Competition and Markets Authority — Court upholds findings that firms charged excessive and unfair prices for NHS-funded medicine
The Competition Appeal Tribunal has affirmed the regulator's decision regarding pharmaceutical companies exploiting dominant positions to inflate costs for the national health service.
This victory impacts UK pharmaceutical manufacturers and distributors, especially those supplying essential medicines to the health service.
Pricing specialists must now prepare for intensified regulatory scrutiny and potential enforcement actions regarding pricing models for medical supplies.

2️⃣ The Pensions Regulator — TPR uses anti-avoidance powers to protect plumbing industry pension scheme
The regulator has exercised statutory anti-avoidance powers to ensure pension scheme members are protected from corporate actions jeopardizing their retirement benefits.
This intervention specifically targets plumbing industry entities and directors to prevent the strategic avoidance of mandatory employer liabilities.
Trustees should immediately review their funding positions to ensure total compliance with regulations and mitigate the risk of future interventions.

3️⃣ Autorité des Marchés Financiers — The AMF Enforcement Committee fines a financial investment advisor and its directors
The French regulator has imposed financial penalties for identified breaches of professional obligations and failures in investment services supervision and licensing compliance.
This enforcement action hits investment advisors and senior management responsible for internal controls within the French financial landscape.
Firms under AMF jurisdiction are advised to audit professional conduct protocols to avoid facing similar disciplinary proceedings and administrative fines.

4️⃣ Komisja Nadzoru Finansowego — Nałożenie kar pieniężnych na Reliance Capital SA
The Polish financial supervisor has issued administrative fines against the entity for failures related to licensing, authorization, and consumer protection standards.
The decision impacts Polish financial institutions and banking providers, emphasizing the importance of adhering to national banking prudential standards.
Market participants should ensure licensing documentation is comprehensive and meets high standards set by the KNF to avoid future penalties.

5️⃣ HM Treasury — IFRS 18 Presentation and Disclosure in Financial Statements Exposure Draft
The government has released an exposure draft proposing changes to how financial statements are structured and disclosed under upcoming IFRS 18 standards.
This regulatory proposal hits corporate finance departments and all listed companies that must align reporting practices with new international frameworks.
Affected entities should begin a preliminary assessment of the impact of these requirements on internal reporting systems before the final implementation phase.

Full analysis in the attached RegNext Daily Europe Radar carousel.

— Elena Navarro · Managing Editor, RegNext
Daily Europe Radar · Tuesday 28 Jul 2026
#EURegulation #UKRegulation #FinancialRegulation #ComplianceIntelligence